Oncology
Evolimus 10
Tablet — 10mg
WHO-GMP
Product Overview
Everolimus tablets belong to the pharmacological class of mTOR inhibitors (mammalian target of rapamycin) and function as selective immunosuppressants and antineoplastic agents
Indications
Everolimus tablets are indicated to treat various advanced cancers, including hormone receptor-positive breast cancer, specific neuroendocrine tumors (pancreas, lung, GI tract), and renal cell carcinoma
Dosage Forms & Strength
Available Forms
Tablet
Strength
10mg
Regulatory Approvals
WHO-GMP